Stay updated on Tucatinib Combo in HER2+ LMD Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo in HER2+ LMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo in HER2+ LMD Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T19:44:55.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    A new Revision: v3.4.3 is added to the history and Revision: v3.4.2 is removed.
    Difference
    0.1%
    Check dated 2026-03-06T18:19:53.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    - The latest revision is v3.4.2, replacing v3.4.1 in the history. This appears to be a minor maintenance update with no change to study data or content.
    Difference
    0.1%
    Check dated 2026-02-13T12:37:34.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 in the page history.
    Difference
    0.1%
    Check dated 2026-02-05T23:52:18.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Minor site release update from Revision: v3.3.3 to v3.3.4; this change does not affect study data, content, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T04:48:29.000Z thumbnail image
  9. Check
    109 days ago
    Change Detected
    Summary
    Footer area updated: removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' and added 'Revision: v3.3.3'.
    Difference
    0.2%
    Check dated 2025-12-24T15:11:05.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo in HER2+ LMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in HER2+ LMD Clinical Trial page.